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Retinitis pigmentosa (RP) is a clinically and genetically 
heterogeneous group of hereditary retinal disorders, being 
one of the most common types of retinal degenerations 
worldwide with a prevalence of 1:4000. So far, 53 genes have 
been associated with RP, whose defects cause a progressive 
loss of rod photoreceptor function, followed by cone photo-
receptor dysfunction often leading to complete blindness [1]. 
At present, 36 genetic loci have been implicated in nonsyn-
dromic autosomal recessive RP (arRP), each of them being 
responsible for a few percent of arRP cases [2].
Enormous efforts have been made in research in recent 
years. With the help of improved molecular genetic and func-
tional diagnostic tools an early recognition and differentiation 
of retinal degenerations has become possible. Homozygosity 
mapping has been proven to be the most efficient tool for 
identifying novel arRP genes [3]. In the Israeli and Palestinian 
population this approach is highly effective, because of rela-
tively high levels of consanguinity, large number of siblings 
in families and presence of isolated subpopulations [4-7].
As a part of an international cooperation, we used homo-
zygosity mapping to identify the disease causing genes in 
families from Israel and the Palestinian Authority with retinal 
disorders. Here we report the identification of a novel muta-
tion in the FAM161A gene in a consanguineous Palestinian 
family with three siblings suffering from RP.
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Purpose: Retinitis pigmentosa (RP) is a heterogenous group of inherited retinal degenerations caused by mutations in 
at least 45 genes. Recently, the FAM161A gene was identified as the causative gene for RP28, an autosomal recessive 
form of RP.
Methods: We performed a clinical and molecular genetic study of a consanguineous Palestinian family with two three 
siblings affected with retinitis pigmentosa. DNA samples were collected from the index patient, his father, his affected 
sister, and two non-affected brothers. DNA sample from the index was subjected to high resolution genome-wide SNP 
array. Assuming identity-by-descent in this consanguineous family we applied homozygosity mapping to identify disease 
causing genes.
Results: The index patient reported night blindness since the age of 20 years, followed by moderate disease progression 
with decrease of peripheral vision, the development of photophobia and later on reduced central vision. At the age of 
40 his visual acuity was counting fingers (CF) for both eyes, color discrimination was not possible and his visual fields 
were severely constricted. Funduscopic examination revealed a typical appearance of advanced RP with optic disc pallor, 
narrowed retinal vessels, bone-spicule like pigmentary changes in the mid-periphery and atrophic changes in the macula. 
His younger affected brother (37 years) was reported with overall milder symptoms, while the youngest sister (21 years) 
reported problems only with night vision. Applying high-density SNP arrays we identified several homozygous genomic 
regions one of which included the recently identified FAM161A gene mutated in RP28-linked autosomal recessive RP. 
Sequencing analysis revealed the presence of a novel homozygous nonsense mutation, c.1003C>T/p.R335X in the index 
patient and the affected sister.
Conclusion: We identified an RP28-linked RP family in the Palestinian population caused by a novel nonsense muta-
tion in FAM161A. RP in this family shows a typical disease onset with moderate to rapid progression into severe visual 
impairment including central vision in the index and overall milder symptoms in the younger brother and sister.
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METHODS
Clinical examination: Informed consent was obtained and 
examinations were carried out respecting the Code of Ethics 
of the World Medical Association (Declaration of Helsinki). 
Approval of the local Ethics Committee was obtained. A 
detailed patient history of the index patient and his affected 
siblings was recorded regarding disease onset, symptoms and 
progression. Visual acuity, visual field and morphological 
examinations of the anterior and posterior segments were 
carried out in the index patient. Furthermore, medical records 
of prior ophthalmological visits were used to complete the 
clinical aspect.
Genetic analysis: Genomic DNA was prepared from periph-
eral venous blood using the MasterPure™ DNA Purifica-
tion Kit (Epicentre, Madison, WI) and stored in TE buffer. 
Whole genome SNP genotyping was done using Affymetrix 
250k_NspI SNP arrays (Affymetrix, Santa Clara, CA) as 
outlined previously [8]. SNP chip genotypes were used for 
mapping of autozygous regions applying the online version 
of the Homozygosity Mapper software [9].
Mutation screening of the FAM161A gene was done by 
complete DNA sequencing of all coding exons and flanking 
intron and UTR sequences from PCR amplified genomic 
DNA. PCR fragments were treated with ExoSAP (GE Health-
care, Freiburg, Germany) and subsequently subjected to 
DNA sequencing applying BigDye Terminator 1.1 chemistry 
(Applied Biosystems, Darmstadt, Germany). All sequences 
were run on an ABI 3100 DNA sequencer, processed with 
the Sequence Analysis 5.1 software (Applied Biosystems) and 
aligned with the reference sequence applying SeqMan (Laser-
gene, Madison WI, USA). Assessment of the c.1003C>T/p.
R335X mutation in controls was performed by pyrose-
quencing on a PyroMark Q96 instrument (Qiagen, Hilden, 
Germany) applying a custom developed SNP assay (PCR 
primers: 5’-AAT TTA TAG CAA GGG AGG AAC AGA-3’ 
and 5’-biotin-GAG GAA TGG GTC TGG CTT TAA-3’; 
sequencing primer: 5’-CAA GGG AGG AAC AGA AG-3’). 
Purification of PCR products and pyrosequencing reactions 
were done following the manufacturer’s protocol (Qiagen).
RESULTS
Clinical findings: One female and two male siblings of a 
consanguineous Palestinian family presented with typical 
symptoms and clinical findings of RP. The older brother (40 
years) had noticed night blindness at the age of 20 years, as 
first symptom of his disease. This has been accompanied by 
photophobia and decreased peripheral vision, and his visual 
function showed a moderate worsening over the next years. 
At time of our examination his visual acuity was counting 
fingers (CF) for both eyes, color discrimination was not 
possible and his visual field showed a severe constriction 
disabling the patient`s self-orientation. He additionally 
reported a history of high myopia with radial keratotomy 
performed in both eyes at the age of 20 years. Current glass 
correction was -9.0 Dpt sphere for both eyes, however, glasses 
did not improve his visual function. Pupillary responses 
and intraocular pressure were normal. Examination of the 
anterior segments revealed numerous radial keratotomy scars 
on both eyes, with the central cornea appearing clear. There 
was no evidence of inflammation in the anterior segments 
and only a mild cataract on the right eye was observed. 
Funduscopic examination revealed slight optic disc pallor, 
narrowed retinal vessels and atrophic appearing maculae on 
both eyes. In the mid-periphery, widespread bone-spicule like 
pigmentary changes could be observed, typical for advanced 
retinitis pigmentosa (Figure 1). His younger brother (37 years) 
presented with overall milder symptoms, disease onset was 
reported at the age of 27 years. The youngest sister (21 years) 
did not report any disturbing visual symptoms, only prob-
lems with night vision were noticed recently. Unfortunately, 
a detailed clinical examination could not be performed.
Genetic findings: DNA samples were collected from the index 
patient, his father, his affected sister, and two non-affected 
brothers after informed consent has been obtained. A DNA 
Figure 1. Morphological f ind-
ings. Fundus pictures of the right 
(R) and left eye (L) of the index 
patient showing pallor optic discs, 
attenuated vessels, and charac-
teristic pigment changes in the 
mid-periphery.
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sample from the affected younger brother was not available. A 
DNA sample from the index was subjected to high resolution 
genome-wide SNP analysis using the Affymetrix 250K NspI 
SNP array. Assuming identity-by-descent in this consan-
guineous family we applied the program Homozygosity 
Mapper [9] for the identification of autozygous region in the 
genome. We observed several larger autozygous regions on 
chromosomes 1, 2, 3, 6, 11 and 16 including a ~ 25 Mb region 
between 47.2 M and 71.4M on chromosome 2. This region 
contains FAM161A, a gene that has been recently found to be 
mutated in arRP families linked to the RP28 locus [10,11]. We 
therefore performed Sanger sequencing of all coding exons 
and flanking intron and UTR sequences of the FAM161A gene 
which led to the identification of a homozygous nonsense 
mutation, c.1003C>T/p.R335X (RefSeq: NM_001201543), in 
the index patient (Figure 2). Segregation analysis within the 
family revealed that both the father and one of the unaffected 
brothers are heterozygous for the mutation whereas the other 
unaffected brother does not carry the mutation. (Figure 2).The 
youngest sister was found to be homozygous for the mutation 
c.1003C>T/p.R335X as well (Figure 2). Applying a custom 
pyrosequencing assay we further excluded the mutation in 87 
ethnically matched controls (= 174 chromosomes) indicating 
that it is a rare variant in this population.
The p.R335X mutation is a novel mutation in FAM161A. 
It is predicted to result in a truncated protein that lacks – 
depending on the splice variant - 305 or 361 amino acid 
residues of the full length protein (Figure 3). However due 
to the location of the nonsense mutation in the central exon 
3, mutant transcripts are expected to undergo nonsense-
mediated mRNA decay. Moreover, truncated proteins are 
mostly unstable and rapidly degraded in the cell. We therefore 
reason, that the p.R335X mutation represent a virtual null 
allele of the FAM161A gene.
DISCUSSION
Retinitis pigmentosa is a genetically highly heterogeneous 
disorder with more than 50 genes currently known to be 
implicated in this condition. For the mapping of new loci and 
subsequent identification of new genes for autosomal reces-
sive forms of RP, homozygosity mapping has been shown 
to be a highly effective method [3]. Homozygosity mapping 
relies on identity-by-descent of the mutant alleles and thus is 
Figure 2. Pedigree and genetic 
findings. The index patient and his 
youngest sister show a homozygous 
nonsense mutation, c.1003C>T/p.
R335X, while both the father and 
one of the unaffected brothers are 
heterozygous for the mutation and 
the other unaffected brother does 
not carry the mutation. The sequencing electropherograms show the homozygous mutant sequence (top) in comparison with a wildtype 
control sequence (bottom).
Figure 3. Structure of the FAM161A 
gene and localization of a currently 
known RP-associated mutation. 
Black bars indicate coding exons 
or exon segments whereas white 
bars represent the 5′ and 3′ untrans-
lated region (UTR), respectively. 
The transcript splicing pattern is 
depicted below showing the two alternatively spliced isoforms including or lacking exon 3a. Most currently known mutations localize to 
exon 3; the novel p.R335X mutation found in this study is shown in red.
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most successful in consanguineous families. Consangineous 
marriages are rather common in the Palestinian population, 
therefore it provides a rich resource of families suitable 
for this approach. In fact, we were able to pick the correct 
candidate gene in this family, although our homozygosity 
mapping solely based on genotype data from a single affected 
individual.
The novel c.1003C>T/p.R335X mutation found in this 
study is just the fifth mutation reported in FAM161A. One of 
the initial gene identification reports relied on a study of RP 
patients from Israel, most of them of Jewish origin. In the 20 
families reported in this study, only three different FAM161A 
mutations were found with the p.T452Sfs mutation being by 
far the most abundant allele [11]. The identification of the 
novel c.1003C>T/p.R335X mutation, different from those 
reported by Bandah-Rozenfeld and colleagues contrasts prior 
reports on genetic relatedness and shared mutations between 
the Jewish and the Palestian/Arab people in the near East 
[12,13]. However we cannot exclude a rather recent origin and 
thus limited spread of the c.1003C>T/p.R335X mutation in the 
Near East populations.
Most currently known mutations [10,11] cluster in exon 
3 of the FAM161A gene (Figure 3), which is by far the largest 
coding exon of the whole gene. The mutations are predicted 
to result in a truncated polypeptide that lacks the carboxy-
terminus of the genuine protein. However, it is likely that the 
mutant transcripts undergo nonsense-mediated mRNA decay 
and thus only little of the truncated protein is expected to be 
synthesized. Interestingly, all four mutations that represent 
single nucleotide substitutions in exon 3 affect one of a total 
of 7 arginine –CGA- codons in this exon. CpG dinucleotides 
are prone to deamination of the cytosine and thus to result in 
the conversion into a –TGA- stop codon, however its abun-
dance in this case is unusual. On average exon 3 of FAM161A 
has a rather normal GC content of 42%. However at least 
some of the mutated –CGA- codons are part of local segments 
with considerably higher GC content which might form DNA 
structures that a more exposed to mutating agents (Figure 4).
Recent studies have shown that FAM161A localizes to 
the base of the connecting cilium in photoreceptors and is 
also associated with the basal body in ciliated mammalian 
cells [14,15]. Moreover, FAM161A interacts with other known 
components of sensory cilia including a number of ciliopathy-
associated proteins [15]. Thus FAM161A is another member 
of the growing list of ciliary proteins implicated in human 
disease and FAM161A-associated RP must be considered as 
a ciliopathy. Phenotypes of ciliopathies are quite diverse and 
may involve impairment of multiple organs or functions such 
as vision, kidney, brain, skeletal abnormalities and obesity 
[16]. However, in the patients investigated in this study we 
did not observe any other obvious features or anamnestic 
history of extraocular symptoms typically related to ciliopa-
thies. The clinical picture features all typical signs of retinitis 
pigmentosa including a history of night blindness as first 
symptom, progressive loss of visual function and charac-
teristic morphological changes. Compared to the patients 
described by Langmann et al [10] and Bandah-Rozenfeld et 
al [11] it seems, that FAM161A-related arRP does not show 
unique clinical features, however, phenotype can be variable 
regarding disease onset and progression. Interestingly, high 
myopia was present in our case, similar to the findings of 
Bandah-Rozenfeld et al in their patient cohort [11].
Figure 4. GC profile of exon 3 of 
FAM161A. The GC profile shows 
local segments of significantly 
elevated GC content.
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In conclusion, we report here a novel c.1003C>T/p.
R335X mutation in the FAM161A gene causing autosomal 
recessive retinitis pigmentosa in a family in the Palestinian 
Arabic population, which further accentuates its presence and 
relevance in Israeli and Palestinian populations.
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